The global contraceptive pills market size is projected to reach USD 20.55 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period. High degree of unfulfilled contraceptive needs in rural areas in emerging economies is expected to be one of the key drivers for the growth of this market. Data gathered under the Demographic and Health Surveys (DHS) conducted between 2005 and 2014 in 52 developing countries revealed that around 8% to 38% of married rural women, aged between 15 and 49 years, faced unmet contraceptive needs. The main reason for this gap is the lack of accessibility and local availability of birth-control pills in these areas. To counter this, governments in many developing and underdeveloped countries are taking efforts to make these modern day medications more accessible and affordable to the rural populace. This will effectively accelerate the oral contraceptives market growth during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-pills-market-101802

 Fortune Business Insights™, in its report, titled “Contraceptive Pills Market Size, Share & Industry Analysis, By Type (Combination Pills and Progestin-only Pills), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGO, and Others) and Regional Forecast, 2019-2026”, states that the value of this market stood at USD 13.11 billion in 2018. In addition to this information, the report shares the following insights:

• A microscopic analysis of the major factors and drivers shaping the market;
• A meticulous research into the most defining regional and competitive dynamics characterizing this market;
• An in-depth profiling of the key players operating in this market; and
• A holistic study of the different market segments.

Expeditious Need to Curb Population Growth to Feed Market Development

According to the United Nations’ Department of Economic and Social Affairs, by 2030, world population will reach 8.6 billion and by 2050, it will be 9.8 billion. The prevalent anxiety is that such explosion of numbers will create wide socio-economic imbalances, especially in poor countries. Proactive measures are being taken by governments across the globe about family planning and use of the contraceptives to avoid unnecessary pregnancies. This desperate need to control population growth is expected to be one of the leading contraceptive pills market trends in the immediate future. Furthermore, increasing prevalence of teenage pregnancies, particularly in the U.S. has also emerged as a central factor driving the growth of this market.

The global contact lenses market size is projected to reach USD 12.05 billion by 2026, exhibiting a CAGR of 4.8% during the forecast period. However, the market was worth USD 8.35 billion in 2018. This information is published in a recent report by Fortune Business Insights, titled, “Contact Lenses Market Size, Share & Industry Analysis, By Modality (Reusable and Disposable), By Design (Toric, Multi-Focal, and Spherical), By Distribution Channel (Retail Stores, Online Stores, and Ophthalmologists), and Regional Forecast, 2019-2026.” As per the report, rising per capita healthcare expenditure and increasing incidence of astigmatism and myopia are expected to affect the market positively.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contact-lenses-market-101775

What Does the Report Contain?

• In-depth information regarding all the possible segments, including modality, design, distribution channel, and region.
• Elaborate analysis of several insights, namely, contact lenses market trends, opportunities, growth drivers, and hindrances.
• Latest industry developments, such as new product launches, mergers, acquisitions, partnerships, and agreements.

Rising Prevalence of Ocular Disorders to Augment Market Growth

The World Health Organization (WHO) stated that approximately 1.7 million people are affected by presbyopia and around 153 million people reside with uncorrected refractive errors around the world. A rising prevalence of presbyopia worldwide is one of the main factors propeling the contact lenses market growth in the coming years. Also, many people are affected by ocular disorders, which in turn, is expected to boost growth of the market.

Spherical Segment to Dominate the Market Backed by High Prescriptions

In terms of design, the market is segregated into spherical, multifocal, and toric. Out of these, the spherical segment had generated 65.8% contact lenses market share in 2018 and was in the leading position. It occurred because these lenses are highly recommended by doctors for correcting ocular disorders

The global cosmeceuticals market size is projected to reach USD 73.73 billion by the end of 2026. Increasing awareness among consumers regarding the advantages of cosmeceuticals over ordinary cosmetics will lead to a wider product adoption.

According to a report published by Fortune Business Insights, titled “Cosmeceuticals Market Size, Share & Industry Analysis, By Product (Skin Care, Hair Care, Injectables and Others), By Distribution Channels (Pharmacy/Drug Stores, Online Stores, and Others), and Regional Forecast, 2019-2026,” the market was worth USD 37.41 billion in 2018 and will exhibit a CAGR of 8.9% during the forecast period, 2019-2026.

For more information in the analysis of this report, visit:

https://www.fortunebusinessinsights.com/cosmeceuticals-market-102521

Product Overview:

Cosmeceuticals are a combination of cosmetic product and pharmaceuticals. They are mainly used in enhancing the physical appearance of the body and enhance skin health. Cosmeceuticals are inclusive of several antioxidants that are responsible for enhancing the surface on which they are applied. The demand for visually appealing lifestyle and changing habits will lead to a wider adoption of cosmeceuticals across the world. The presence of several large scale vendors will emerge in favor of the growth of the overall cosmeceuticals market. The growing demand for natural products with minimum side effects will open up a huge potential for the companies operating in the market. The availability of cosmeceuticals at a low cost will contribute to market growth.

Little Optimism for SMEs; Extended Lockdowns Doing More Damage than Earlier Predictions

As Covid-19 cases continue to rise, businesses are doing their best to adopt strategies that will help them run through online platforms, be it marketing or even distribution of the product. It is evident that large scale firms can shake off the impact of the pandemic. The negativities of the coronavirus will prove a bit much for the small and medium enterprises and it is likely that most of the small enterprises may not even be able to recover from this. Although this is bad for SMEs, the coast will be clear for large scale businesses as well as manufacturers as less competition will bring more opportunities. Although e-commerce trading is active in most of the countries, there is hesitancy among people to buy cosmetic products; let alone using them on sensitive body parts such as skin.

The global e-prescribing market size is expected to touch USD 4,017.79 million by the end of 2026, attributable to the incorporation of e-prescribing software in the Electronic Health Record (EHR) solutions. E-prescribing or electronic prescribing is a new technologic infrastructure that helps the medical professionals to write and send prescriptions directly to the pharmacy. Fortune Business Insights, in its recent report, titled, “E-prescribing Market Size, Share & Industry Analysis, By Delivery Mode (Web-based, On-premise), By Prescription Type (Controlled substance, Non controlled Substances) By End User (Hospitals, Physician’s offices, Pharmacies) and Regional Forecast, 2019-2026,” states that the value of the market was USD 863.64 million in 2018 and will exhibit a CAGR of 21.0% during 2019 to 2026.

For more information in the analysis of this report, visit:  https://www.fortunebusinessinsights.com/e-prescribing-market-102698

The current outbreak of the COVID-19 pandemic has stirred the global economy. Most of the international trade is at halt now, while some are struggling to generate meagre revenues. Governments of various nations have imposed safety regulations. We hope to fall out of this situation to a better one soon. Fortune Business Insights is offering a few individual reports on the impacts of coronavirus on various markets. These reports will benefit the investors to chalk out the revenue generation plans during this situation accordingly.

Cost-efficiency Features to Add Boost to Market

The e-prescribing software program allows doctors to transmit a prescription to the pharmacies and healthcare clinics without losing any medical history of the patient. This, coupled with the associated benefits, such as quality medical care and improved safety of the patients, are the key factors promoting the electronic prescribing market growth. Additionally, they are convenient for both the physician and the patient. They are more cost-efficient, as compared to the traditional prescription methods. It would, thereby augment the growth of the market during the forecast period.

On the flip side, implementing a new e-prescribing setup is expensive and requires high cost for maintenance, as well. This may hamper the market growth in the coming years. Nevertheless, the adoption of these therapeutic solutions in emerging economies is expected to create new opportunities for the market to flourish in the coming years. Nevertheless, the prevalence of various diseases requiring outpatient checkup services is likely to create lucrative growth opportunity in the near future.

The global medical lasers market will witness considerable growth due to growing applications of medical lasers in surgical procedures. According to a report published by Fortune Business Insights, titled “Medical Lasers: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 3,778.9 Mn in 2018. Fortune Business Insights has predicted that the market will reach US$ 12,327.8 Mn by 2026, thereby exhibiting a CAGR of 15.9%.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/medical-lasers-market-101071

The ability of medical lasers to treat damaged or targeted tissues, through a minimally invasive procedure, has led to a huge demand across the world. Medical lasers possess the ability to diagnose and treat several diseases, which in turn will lead to a rising adoption across the world. The use of laser radiation comes with certain challenges; recent scientific advancements will favor the growth of the global medical lasers market in the forthcoming years. Resulting from the high demand, there have been numerous technological advancements in the manufacture of these equipment and this, according to Fortune Business Insights will constitute an increase in the global medical lasers market value in the forthcoming years. Growing applications of medical lasers have led to numerous clinical trials, which in turn has aided the growth of the global medical lasers market in recent years. The report focuses on several factors that have accounted for the growth of the global medical lasers market in the coming years.

Backed by Exceptional Product Portfolios, El.En. S.p.A., Lumenis, and Ellex Medical Lasers Ltd., Dominated the Market in 2018

The global medical lasers market is semi-consolidated in nature. Three of the leading medical lasers market companies have accounted for maximum share of the global medical lasers market. Accounting to their strong market presence, combined with a renowned market brand, El.En. S.p.A., Lumenis, and Ellex Medical Lasers Ltd., dominated the global medical lasers market in 2018. Having said that, increasing efforts put in by other medical lasers market companies have showcased massive potential and consolidation is likely to be diminished in the coming years.

The global psoriasis treatment market size is anticipated to touch USD 37,634.2 million by 2026 owing to the increasing number of psoriasis cases. Some studies say that psoriasis may further develop other chronic diseases that cause harm to the immune system of the body. These include non-melanoma skin cancer, psoriatic arthritis, lung cancer, depression, metabolic syndrome, cardiac disorders, COPD (chronic obstructive pulmonary disease), and others. It may also cause polycystic ovarian syndrome and pregnancy complications in women. A recent report by Fortune Business Insights offers a qualitative and quantitative analysis of this market and its growth parameters. As per this report titled, “Psoriasis Treatment Market Size, Share and Industry Analysis By Drug Class (TNF Inhibitors, Interleukins, Others), By Type (Plaque Psoriasis, Psoriatic Arthritis, Others), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online pharmacies), and Regional Forecast 2019-2026,” According to this report, the market value stood at USD 18,378.0 million in 2018 and will exhibit a CAGR of 9.4% between 2019 to 2026.

visit: https://www.fortunebusinessinsights.com/industry-reports/psoriasis-treatment-market-100600

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this, too, shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. Some industries are struggling, and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic

TNF Inhibitors Segment to be Overpowered in Forecast Years Due to Declining Prices of Branded Products

Based on segmentation by drug class, the TNF inhibitors segment was dominating the market in the past. In 2018, this segment earned a 46.3% psoriasis treatment market share. However, the advent of biosimilar and increasing prescription volume for interleukin inhibitors resulted in a decline in the rate of branded products. Owing to the factor stated above, the interleukin inhibitors segment is likely to overpower the TNF inhibitors segment in the coming years.

FDA Approvals for Clinical Trails – Key Objective of Players

Companies are engaging in clinical trials, research and development, and other innovative ideas and massively investing in the same to make their mark in the competition. They are also focused on gaining clinical approvals from the Food and Drug Administration (FDA) which will further add more revenue to the market.

The global pressure ulcer (PU) treatment market is expected to gain momentum from the rising adoption of innovative wound care devices for treatment. As per the Agency for Healthcare Research & Quality (AHRQ), in the U.S., more than 2.5 million people get affected by pressure ulcers annually. It proves that the increasing geriatric population, coupled with upsurging cases of PU would affect the market positively in the coming years.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/pressure-ulcer-treatment-market-102095

This information is provided by Fortune Business Insights™ in a recent study, titled, “Pressure Ulcer (PU) Treatment Market Size, Share & Industry Analysis, By Ulcer Type (Stage 1, Stage 2, Stage 3, Stage 4), By Product (Wound-care Dressings, Wound-care Devices, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2019-2026.” The study further states that the pressure ulcer treatment market size is projected to reach USD 11.23 billion by 2026, thereby exhibiting a CAGR of 6.7% during the forecast period. However, it stood at USD 6.69 billion in 2018.

The Report Answers the Following Questions:

• What are the most vital pressure ulcer market trends, opportunities, and challenges?
• How many growth drivers and hindrances will the market face?
• Which region will remain at the forefront throughout the forecast period?
• Which segment will dominate in terms of share?
• What are the strategies adopted by renowned companies to increase sales?

Driver

Rising Patent Pool Worldwide to Augment Growth

In the 20^th century, a pressure ulcer was considered to be one of the costliest and the most physically debilitating complications. Factors, such as mobility problems, sedentary lifestyle, advancing age, and other similar health issues are mainly responsible for surging the incidence of PU worldwide. The National Center for Biotechnology Information (NCBI) declared that in 2018, the prevalence of pressure ulcers in Ethiopia, Turkey, and Brazil was 16%, 10.4%, and 12.7%, respectively. This indicates that there is a large patient pool seeking medical help across the globe. In addition to that, rising healthcare expenditure in the developing economies, as well as increasing awareness campaigns regarding the availability of various treatment options, would fuel the pressure ulcer treatment market growth during the forthcoming years.

The global bovine lactoferrin market size is projected to reach USD 949.0 million by the end of 2027. Technological advancements in manufacturing processes will have a positive impact on the growth of the overall market in the coming years. According to a report published by Fortune Business Insights, titled “Bovine Lactoferrin Market Size, Share & COVID-19 Impact Analysis, By Product (Spray-dried, and Freeze-dried), By Application (Infant Formula, Pharmaceuticals, Dietary Supplements, Food, and Others), and Regional Forecast, 2020-2027,” the market was worth USD 546.6 million in 2019 and will exhibit a CAGR of 5% during the forecast period, 2020-2027.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/bovine-lactoferrin-market-101656

Lactoferrin is an anti-microbial that has the ability to fight severe diseases such as Crohn’s disease. The product is a protein that protects the body from necrotizing enterocolitis and is also used to reduce conditions such as diarrhea. The product is said to boost the fight against intestinal ulcers and critical diseases such as hepatitis C. Accounting to its properties, lactoferrin is used to treat viral infections. The substance is found in human milk like colostrum, the first milk produced after the baby is born. Due to several advantages of the product with regard to human health, bovine lactoferrin is being studied on a wider scale across the world. The massive investments in research and development of the product associated with its effects on human health will bode well for the growth of the overall market in the coming years.

Increasing Number of Product Launches will Contribute to Market Growth

The report encompasses several factors that have contributed to the growth of the overall market in recent years. Among all factors, the constant innovations associated with bovine lactoferrin, coupled with the increasing number of variants introduced by large scale companies, has had the highest impact on the growth of the market in recent years. The report includes the strategies adopted by these companies, along with their respective products in bovine lactoferrin industry. In April 2018, Ingredia announced the launch of a new lactoferrin in the global market

The rapid adoption of electronic medical records and electronic health records by companies across the world drives the global revenue cycle management market or RCM market. Fortune Business Insights in its new report, titled “Revenue Cycle Management: Global Market Analysis, Insights and Forecast 2018-2025” predicts the market to grow at a remarkable rate during the forecast period. North America is expected to contribute significantly towards the growth of the revenue cycle management market.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/revenue-cycle-management-market-100275

Some of the major companies that are present in the Global Revenue Cycle Management Market are;

• Microsoft
• IBM
• Dell
• McKesson
• Experian
• Allscripts
• Athenahealth
• Greenway Health
• GeBBS Healthcare Solutions
• ZirMed, now part of Waystar
• Epic Systems Corporation
• General Electric Manufacturing Company Cerner Corporation

The rising adoption of RCM among end users and presence of well-established healthcare infrastructure is expected to drive the RCM market in North America. In addition to this, revenue cycle management solutions offer long-term benefits, which is a key reason behind its high uptake in the region. Furthermore, the increasing presence of physicians and hospitals in North America will fuel the demand for revenue cycle management services in the coming years.

According to studies, Asia Pacific is projected to exhibit a high growth in the global RCM market. The growth is primarily attributable to the rising target population looking for medical claims and treatment. Moreover, the market is expected to witness exceptional growth opportunities in India, China, Singapore, and Japan.

The global respiratory syncytial virus (RSV) therapeutics market size is estimated to showcase potential growth owing to its increasing adoption against the prevention and treatment of the disease, observes Fortune Business Insights™ in an upcoming report, titled, “Respiratory Syncytial Virus (RSV) Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Prophylaxis and Treatment), By End-user (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2020-2027.” The respiratory syncytial virus (RSV) therapeutics market stood at USD 1,111.3 million in 2019. It is projected to grow from USD 609.2 million in 2020 to USD 4,003.4 million in 2027 at a CAGR of 30.9% in the forecast period.

For More Questions, Talk with Respiratory Syncytial Virus (RSV) Therapeutics Industry Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/respiratory-syncytial-virus-rsv-therapeutics-market-104668

High Production Scale to Hinder Growth Opportunities in Global Pharmaceutical Space

The COVID-19 contagion is expected to drive the global pharmaceutical industry. Enterprises across the world along with governments from several nations are contributing to the development and distribution of the vaccine. However, the scale at which the production is assumed to take place is a major challenge for most of the renowned players. At Fortune Business Insights™, we are providing actionable insights by closely studying multiple aspects of the current scenario. We are also offering firsthand information on various market trends through our comprehensive research reports.

New Product Launches from Key Players Helped Prophylaxis Segment Hold Largest Share In 2019

Based on drug class, the prophylaxis segment led the market with the largest share in 2019. Potential approvals and launch of maternal vaccines by companies including Pfizer and GSK are estimated to help the segment further dominate the market during the forecast timeframe. Based on end-user, the hospital pharmacy segment dominated the global market owing to the high demand for healthcare professionals for the existing treatment and prevention options.